Norman Swan
speaker
15,981 appearances
143 recordings
2 series
first heard Jul 2005
last heard 2d ago
Norman Swan’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 24 in all, peaking in Jun 2026 with 7.
Appearances
Really where the the outcome was seen that all these headlines have focused on is in this coronary revascularization group, which we should be clear is very cardiologist-dependent.
matched
They're more likely to go and intervene on people with a high cholesterol.
matched
There's a lot of nuance and grey there.
matched
But you get symptomatic improvement.
matched
You might get less symptoms if you have the stent in.
matched
But I think the long and the short of this is am I putting every patient now over seventy on a statin because of this study?
matched
Because that's what the headlines have suggested.
matched
It is
matched
Yes, possibly, because they'll earn a lot more money than they already are, although they're earning enough, I would argue.
matched
But
matched
It's a lot more nuanced.
matched
There's a lot of discussion about deprescribing in patients as they age to r to improve quality of life, take stuff out of the Webster pack, reduce the risk of side effects, adverse effects.
matched
So it's not that clear cut.
matched
It's nuanced.
matched
You have to chat to your health professional.
matched
But actually, Norman, the number needed to treat in this was 37.
matched
Yes, and we have a calculator for that.
matched
There are these scores, there's all this stuff, Norman, but at the end of the day it comes down to the patient in front of you and everyone has different CSAW risk benefit pros and cons.
matched
And I might have two seventy three year old patients and one will choose the statin and one won't, and they're both okay.
matched
They're both fine decisions.
matched
Showing 641–660 of 15,981 · page 33 of 800
← Previous
Next →